Abstract Body

Background

People with HIV (PWH) are at elevated cardiovascular disease (CVD) risk. Traditional risk prediction tools underestimate CVD risk among PWH and do not predict risk of heart failure (HF). The American Heart Association (AHA) developed new risk prediction equations, Predicting Risk of cardiovascular disease EVENTs (PREVENT), which include risk of HF and has not been studied among PWH.

Methods

Using a real-world, electronic health record cohort of PWH over age 40 without known atherosclerotic cardiovascular disease (ASCVD) at two healthcare systems in San Francisco from 2019-2024, we calculated predicted CVD risk using PREVENT, including 10-year ASCVD, heart failure (HF), and total CVD. We compared predicted 10-year ASCVD risk using the pooled cohort equations (PCE) and PREVENT (full equations) both overall and across demographic categories. 

Results

Among 837 PWH, the median age was 57 years old (IQR 48, 63); 67% were male, 17% were female, and 8% were transgender or nonbinary; 29% identified as Black and 25% as Latino; 88% were on antiretroviral therapy and 89% had virologic suppression. Using PREVENT, the median 10-year predicted risk of ASCVD, HF, and CVD were 2.76% (IQR 1.18, 5.61), 12.80% (9.46, 16.7), and 5.28% (2.76, 8.98), respectively, compared to the PCE predicted risk of ASCVD of 7.55% (3.56, 14.5). 

Among 574 PWH with complete data to calculate 10-year ASCVD risk using both equations, predicted risk was lower for 95% of individuals using PREVENT (Panel A). Using a 10-year ASCVD risk threshold of 5% for statins, 56% fewer PWH would be strongly recommended for statins with the PREVENT equations compared to the PCE. The difference in predicted risk between the two equations varied across sex and race/ethnicity groups (Panel B). Adjusted for traditional risk factors, the PREVENT equations predicted lower ASCVD risk than the PCE among those with older age (P<0.0001), male sex (p<0.0001), Black race (P<0.002), and Latino ethnicity (P=0.03).    

Conclusions

The new PREVENT calculator was associated with a lower predicted ASVCD for PWH as compared to the PCE, which was already known to underpredict risk for PWH especially among women and Black individuals. Underprediction of CVD risk, which may translate to lower use of statins and blood pressure treatment, has the potential to increase CVD and worsen healthcare disparities among PWH.